These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 5537801)
1. The medicolegal aspects of adverse drug reactions. Bernstein HN; Levine AM Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801 [No Abstract] [Full Text] [Related]
2. Liability for adverse drug reactions. Francisco CJ Tex Med; 1990 May; 86(5):42-6. PubMed ID: 2343420 [TBL] [Abstract][Full Text] [Related]
3. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
4. The liability of drug manufacturers and physicians. Stratton WT Kans Med; 1987 Oct; 88(10):298-9. PubMed ID: 3682544 [No Abstract] [Full Text] [Related]
5. Drug manufacturers' liability for injuries due to drug abuse. Davis WA Leg Med Annu; 1974; 0(0):425-43. PubMed ID: 4461874 [No Abstract] [Full Text] [Related]
6. Therapeutic freedom. Trout ME J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704 [No Abstract] [Full Text] [Related]
7. Physicians' liability for failure to anticipate and control reactions and interactions precipitated by prescribed or administered drugs. Junewicz JJ Med Trial Tech Q; 1979; 26(1):8-41. PubMed ID: 502810 [No Abstract] [Full Text] [Related]
8. Physicians' liability for failure to anticipate and control reactions and interactions precipitated by prescribed or administered drugs. Junewicz JJ Leg Med Annu; 1977; 1976():327-49. PubMed ID: 865226 [No Abstract] [Full Text] [Related]
9. Drug reactions: the role of the package insert. Barnett FJ J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069 [No Abstract] [Full Text] [Related]
11. Are drugs approved by the FDA safe and risk free? Natl Med Leg J; 1991; 2(1):8. PubMed ID: 2018814 [TBL] [Abstract][Full Text] [Related]
12. Implications of drug reactions--recognition, incidence and prevention. Cooper JW R I Med J (1974); 1975 Jun; 58(6):274-80, 287-8. PubMed ID: 124935 [No Abstract] [Full Text] [Related]
13. Patient package inserts--instructions or intrusions? Harvey MW Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481 [No Abstract] [Full Text] [Related]
14. The medicolegal significance of the package insert. Hirsh HL Conn Med; 1978 Dec; 42(12):785-8. PubMed ID: 720048 [No Abstract] [Full Text] [Related]
15. Food and Drug Administration's adverse drug reaction monitoring program. Lee B; Turner WM Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138 [TBL] [Abstract][Full Text] [Related]
17. Lessening liability associated with new drugs and drug reactions. Zimmerly JG J Leg Med (N Y); 1976 Jan; 4(1):25-7. PubMed ID: 1082474 [No Abstract] [Full Text] [Related]
18. Adverse drug reactions. Fisher RL Am J Gastroenterol; 1987 Apr; 82(4):355. PubMed ID: 3565342 [No Abstract] [Full Text] [Related]
19. Lethal drug interactions. Martin EW Tex Med; 1973 Jan; 69(1):39-55. PubMed ID: 4631428 [No Abstract] [Full Text] [Related]
20. Problems associated with developing orphan drugs into available therapy. Van Woert MH Prog Clin Biol Res; 1985; 197():171-3. PubMed ID: 4070291 [No Abstract] [Full Text] [Related] [Next] [New Search]